Stockreport

Fresenius Kabi Introduces New Presentation of Otulfi® (ustekinumab-aauz), a Biosimilar to Stelara® [Yahoo! Finance]

FRESENIUS SE S/ADR  (FSNUY) 
NASDAQ:AMEX Investor Relations: fresenius.com/index
PDF LAKE ZURICH, Ill., January 06, 2026 BUSINESS WIRE )--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical techno [Read more]